In an interview with Expana at EuroTier 2026, which took place in Hanover, Germany, this week, Huvepharma – recognized for its veterinary pharmaceuticals, coccidiosis control and fermentation products portfolio – said it remains on track to deliver double-digit annual growth, with new markets, new species, and added fermentation capacity at the center of its plans.
Ramon Soriano, Vice President of Sales and Marketing at Huvepharma, said the company is holding to the target it set in December 2025 of continued double-digit annual growth through organic expansion, new product lines and geographic development, but did not provide specific 2026 sales figures.
“We’re on track everything with that target. We will keep on with this organic growth and we continue to focus on markets in Asia Pacific and in Latin America,” Soriano said. He added that the company wants to establish new affiliates, one by one, to support that expansion, and to target species it has not looked at too much before, such as aqua. To go with that, two new product launches in the vaccine segment are planned for 2027.
Capacity is a second pillar of the strategy. In July 2026, Huvepharma agreed to acquire 100% of Euroapi Italy S.r.l., including the Brindisi manufacturing site, which has specialized in microbiological fermentation since 1966. The deal is expected to lift Huvepharma’s fermentation capacity by 25%, to more than 12,000 cubic meters. Soriano said the acquisition was completed a few months ago.
“We needed the capacity and it’s attractive because it’s European-based, and not many companies were of that size and with that fermentation capacity were available,” he said.
Asked about 2027 priorities, Soriano said the focus will most likely be on marketing and sales, new species and new products, adding that “we also want to increase our capacity, for sure, and capacity will follow the growth of the company. That’s a good sign of Huvepharma’s health today.”
“Also it’s about service, service, and service. That’s the main differentiator and what we need to do in order to create something that customers can trust.”
Written by Simon Duke